Ricola Ag

Form 483 issued February 18, 2022 · Laufen, Switzerland

Inspection
Feb 14 – Feb 18, 2022
Investigator
Matthew B. Casale
Observations
1
Pages
1
FEI number
1000170866

In short: On February 18, 2022, FDA issued a Form 483 with 1 observation to Ricola Ag in Laufen, Switzerland (FEI 1000170866) after an inspection that ran Feb 14 – Feb 18, 2022. The investigator was Matthew B. Casale. Most observations concern quality system; the most-cited regulation is 21 CFR 211.192 (production record review).

At a glance

1 of 1 observations on this 483 concern quality system.

Quality system1

Most cited: 21 CFR 211.192 (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Ricola Ag?

FDA listed 1 observation on this Form 483, mostly about quality system. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.

Who inspected Ricola Ag?

Matthew B. Casale is named on this Form 483, for the inspection of Feb 14 – Feb 18, 2022. Each investigator has a profile showing what they cite most.

When was Ricola Ag inspected by FDA?

The inspection ran Feb 14 – Feb 18, 2022, and the Form 483 is dated February 18, 2022.

How do I get the full Form 483 for Ricola Ag?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free